Back to search
FDAFDA · Food and drugs·Recall number D-0227-2022

Ezetimibe and Simvastatin Tablets, 10 mg/40mg, a) 90 Tablets, b) 500 tablets, Rx only, Manufactured by Dr. Reddy's Laboratories LA LLC Shreveport, LA 71106 USA, Packaged by GSMS, Incorporated Camarillo, CA 93012 USA; NDC: a) 51407-192-90, b) 51407-192-05

Published November 17, 2021 · Recall initiated: October 14, 2021

Summary

FDA records drug Class II recall D-0227-2022, published November 17, 2021 and initiated October 14, 2021. Recalling firm: Golden State Medical Supply Inc.; Status: Terminated; Reported quantity: a) 101 b) 145 bottles; Lot: a) Lot: GS038610, Exp: 01/2023; b) GS038891, Exp: 1/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

What to do

Voluntary: Firm initiated · Letter

Get an email if EZETIMIBE AND SIMVASTATIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
EZETIMIBE AND SIMVASTATIN
Manufacturer
Golden State Medical Supply Inc.
Distributor
Distributed to two distributors located in AZ and MO
Lot
a) Lot: GS038610, Exp: 01/2023; b) GS038891, Exp: 1/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ezetimibe and Simvastatin Tablets, 10 mg/40mg, a) 90 Tablets, b) 500 tablets, Rx only, Manufactured by Dr. Reddy's Laboratories LA LLC Shreveport, LA 71106 USA, Packaged by GSMS, Incorporated Camarillo, CA 93012 USA; NDC: a) 51407-192-90, b) 51407-192-05 recalled?

Yes. FDA published recall D-0227-2022 on November 17, 2021. Reported hazard: Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: EZETIMIBE AND SIMVASTATIN.